These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
4. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database. Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452 [TBL] [Abstract][Full Text] [Related]
5. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary. Lee YV; Wahab HA; Choong YS Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791 [TBL] [Abstract][Full Text] [Related]
6. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics. Zhou M; Xie L; Yang Z; Zhou J; Xie J J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679 [TBL] [Abstract][Full Text] [Related]
7. Targeting isocitrate lyase for the treatment of latent tuberculosis. Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043 [TBL] [Abstract][Full Text] [Related]
8. Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase. Shukla H; Kumar V; Singh AK; Singh N; Kashif M; Siddiqi MI; Yasoda Krishnan M; Sohail Akhtar M Biochimie; 2015 Mar; 110():73-80. PubMed ID: 25576828 [TBL] [Abstract][Full Text] [Related]
9. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility. Shukla H; Shukla R; Sonkar A; Pandey T; Tripathi T Sci Rep; 2017 Apr; 7(1):1058. PubMed ID: 28432345 [TBL] [Abstract][Full Text] [Related]
10. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site. Shukla R; Shukla H; Tripathi T Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315 [TBL] [Abstract][Full Text] [Related]
11. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916. Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209 [TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivator of isocitrate lyases 1 and 2 from Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711 [TBL] [Abstract][Full Text] [Related]
14. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus. Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial antibodies by phage display: Identification of antibody-based inhibitor against mycobacterium tuberculosis isocitrate lyase. Ch'ng ACW; Schepergerdes L; Choong YS; Hust M; Lim TS Mol Immunol; 2022 Oct; 150():47-57. PubMed ID: 35987135 [TBL] [Abstract][Full Text] [Related]
16. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251 [TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages]. Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266 [TBL] [Abstract][Full Text] [Related]
19. Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening. Ji L; Long Q; Yang D; Xie J Int J Biol Sci; 2011 Apr; 7(3):376-82. PubMed ID: 21494431 [TBL] [Abstract][Full Text] [Related]
20. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]